acyclovir

Generic: acyclovir

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler bryant ranch prepack
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

acyclovir 200 mg/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 72162-1704
Product ID 72162-1704_ef5933e8-c890-495a-9c97-b73b7d579c9b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075677
Marketing Start 2006-03-20
Marketing End 2027-04-30

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 721621704
Hyphenated Format 72162-1704

Supplemental Identifiers

RxCUI
197310
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA075677 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 120 CAPSULE in 1 BOTTLE (72162-1704-0)
  • 100 CAPSULE in 1 BOTTLE (72162-1704-1)
  • 25 CAPSULE in 1 BOTTLE (72162-1704-2)
  • 30 CAPSULE in 1 BOTTLE (72162-1704-3)
  • 35 CAPSULE in 1 BOTTLE (72162-1704-4)
  • 20 CAPSULE in 1 BOTTLE (72162-1704-5)
  • 60 CAPSULE in 1 BOTTLE (72162-1704-6)
  • 50 CAPSULE in 1 BOTTLE (72162-1704-7)
  • 40 CAPSULE in 1 BOTTLE (72162-1704-8)
  • 90 CAPSULE in 1 BOTTLE (72162-1704-9)
source: ndc

Packages (10)

72162-1704-0 120 CAPSULE in 1 BOTTLE (72162-1704-0) 72162-1704-1 100 CAPSULE in 1 BOTTLE (72162-1704-1) 72162-1704-2 25 CAPSULE in 1 BOTTLE (72162-1704-2) 72162-1704-3 30 CAPSULE in 1 BOTTLE (72162-1704-3) 72162-1704-4 35 CAPSULE in 1 BOTTLE (72162-1704-4) 72162-1704-5 20 CAPSULE in 1 BOTTLE (72162-1704-5) 72162-1704-6 60 CAPSULE in 1 BOTTLE (72162-1704-6) 72162-1704-7 50 CAPSULE in 1 BOTTLE (72162-1704-7) 72162-1704-8 40 CAPSULE in 1 BOTTLE (72162-1704-8) 72162-1704-9 90 CAPSULE in 1 BOTTLE (72162-1704-9)

Ingredients (1)

acyclovir (200 mg/1)

Linked Drug Pages (1)

ACYCLOVIR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ef5933e8-c890-495a-9c97-b73b7d579c9b", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["e5356160-cb35-4ff6-91d5-2ade594e0279"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (72162-1704-0)", "package_ndc": "72162-1704-0", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (72162-1704-1)", "package_ndc": "72162-1704-1", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "25 CAPSULE in 1 BOTTLE (72162-1704-2)", "package_ndc": "72162-1704-2", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (72162-1704-3)", "package_ndc": "72162-1704-3", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "35 CAPSULE in 1 BOTTLE (72162-1704-4)", "package_ndc": "72162-1704-4", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "20 CAPSULE in 1 BOTTLE (72162-1704-5)", "package_ndc": "72162-1704-5", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (72162-1704-6)", "package_ndc": "72162-1704-6", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "50 CAPSULE in 1 BOTTLE (72162-1704-7)", "package_ndc": "72162-1704-7", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "40 CAPSULE in 1 BOTTLE (72162-1704-8)", "package_ndc": "72162-1704-8", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (72162-1704-9)", "package_ndc": "72162-1704-9", "marketing_end_date": "20270430", "marketing_start_date": "20240717"}], "brand_name": "ACYCLOVIR", "product_id": "72162-1704_ef5933e8-c890-495a-9c97-b73b7d579c9b", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "72162-1704", "generic_name": "ACYCLOVIR", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACYCLOVIR", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA075677", "marketing_category": "ANDA", "marketing_end_date": "20270430", "marketing_start_date": "20060320"}